Compare SK Hynix (SKHY) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SK Hynix vs State Street SPDR S&P Biotech ETF — how do they compare? SK Hynix trades at $169.64 (market cap $891.31B), while State Street SPDR S&P Biotech ETF trades at $153.81 (market cap $10.11B). The key difference: SK Hynix is far larger — about 88.2× State Street SPDR S&P Biotech ETF's market cap, and SK Hynix pays a 0.06% dividend while State Street SPDR S&P Biotech ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold SK Hynix for 10 Days and State Street SPDR S&P Biotech ETF for 38 Days on average.
| SKHY | XBI | |
|---|---|---|
Market Cap | $891.31B | $10.11B |
Volume | 22,268,296 | 12,903,266 |
Sector | Technology | Broad Market / Factor |
52-Week High | $198.63 | $169.55 |
52-Week Low | $126.79 | $104.99 |
Typical Hold Time | 10 Days | 38 Days |
Enterprise Value | $841.45B | — |
Dividend Yield | 0.06% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XBI trades at $153.84, up 2.4% today, but technical indicators signal a bearish trend with resistance at $154. The ETF's modified equal-weight structure offers broad biotech exposure, benefiting from M&A activity and positive clinical catalysts, though key financial ratios are unavailable. Recent news highlights sector optimism driven by cancer vaccine breakthroughs and improved capital access.
Outlook is mixed: bullish sentiment from innovation and M&A supports growth potential, but high volatility and expense ratios relative to peers pose risks. Analyst consensus is neutral (100% Hold), suggesting cautious optimism amid technical bearishness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About SK Hynix
SK hynix is a South Korean semiconductor company that manufactures memory products, including DRAM and NAND flash. Its high-bandwidth memory (HBM) products are designed for high-performance computing and AI applications.
Read more on SKHY →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
